Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 3, 2005, Pages 884-890

  Hsu, Stephen ^a   Yamamoto, Tetsuya ^b   Borke, James ^a   Walsh, Douglas S ^c   Singh, Baldev ^a   Rao, Sushma ^a   Takaaki, Kamatani ^b   Nah Do, Nam ^a   Lapp, Carol ^a   Lapp, David ^a   Foster, Emily ^a   Bollag, Wendy B ^a   Lewis, Jill ^a   Wataha, John ^a   Osaki, Tokio ^b   Schuster, George ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 14; CYCLIN DEPENDENT KINASE; EPIGALLOCATECHIN GALLATE; PROTEIN P57; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PSORIASIS; SQUAMOUS CELL CARCINOMA; TEA; UPREGULATION;

CASPASE 14; CASPASES; CATECHIN; CELL DIFFERENTIATION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P57; EPIDERMIS; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; NUCLEAR PROTEINS; RNA, MESSENGER; TEA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 20044385241     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.076075     Document Type: Article

References (38)

1. Adhami VM, Ahmad N, and Mukhtar H (2003) Molecular targets for green tea in prostate cancer prevention. J Nutr 133:2417S-2424S.
2. Ahmad M, Srinivasula SM, Hegde R, Mukattash R, Fernandes-Alnemri T, and Alnemri ES (1998) Identification and characterization of murine caspase-14, a new member of the caspase family. Cancer Res 58:5201-5205.
3. Alonso L and Fuchs E (2003) Stem cells of the skin epithelium. Proc Natl Acad Sci USA 100 (Suppl 1):11830-11835.
4. Balasubramanian S, Efimova T, and Eckert RL (2002) Green tea polyphenol stimulates a Ras, MEKK1, MEK3 and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J Biol Chem 277:1828-1836.
5. Chang TS, Kim MJ, Ryoo K, Park J, Eom SJ, Shim J, Nakayama KI, Nakayama K, Tomita M, Takahashi K, et al. (2003) p57KIP2 modulates stress-activated signaling by inhibiting c Jun NH2-terminal kinase/stress-activated protein kinase. J Biol Chem 28:48092-48098.
6. Deschenes C, Vezina A, Beaulieu JF, and Rivard N (2001) Role of p27 (Kip1) in human intestinal cell differentiation. Gastroenterology 120:423-438.
7. Eckhart L, Ban J, Fischer H, and Tschachler E (2000a) Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation. Biochem Biophys Res Commun 277:655-659.
8. Eckhart L, Declercq W, Ban J, Rendl M, Lengauer B, Mayer C, Lippens S, Vandenabeele P, and Tschachler E (2000b) Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Investig Dermatol 115:1148-1151.
9. Hsu S, Bollag WB, Lewis J, Huang Q, Singh B, Sharawy M, Yamamoto T, and Schuster G (2003a) Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. J Pharmacol Exp Ther 306:29-34.
10. Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, Athar M, Porter AG, and Schuster G (2003b) Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis. Anticancer Res 23:1533-1540.
11. Hsu S, Lewis JB, Borke JL, Singh B, Dickinson DP, Caughman GB, Athar M, Drake L, Aiken AC, Huynh CT, et al. (2001) Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression. Anticancer Res 21:3743-3748.
12. Hsu S, Yu FS, Lewis J, Singh B, Borke J, Osaki T, Athar M, and Schuster G (2002a) Induction of p57 is required for cell survival when exposed to green tea polyphenols. Anticancer Res 22:4115-4120.
13. Hsu S, Yu FX, Huang Q, Lewis J, Singh B, Dickinson D, Borke J, Sharawy M, Wataha J, Yamamoto T, et al. (2003c) A mechanism-based in vitro anticancer drug screening approach for phenolic phytochemicals. Assay Drug Dev Technol 1:611-618.
14. Hsu SD, Singh BB, Lewis JB, Borke JL, Dickinson DP, Drake L, Caughman GB, and Schuster GS (2002b) Chemoprevention of oral cancer by green tea. Gen Dent 50:140-146.
15. Hu PP, Datto MB, and Wang X-F (1998) Molecular mechanisms of transforming growth factor-β signaling. Endocr Rev 19:349-363.
16. Ito Y, Takeda T, Sakon M, Tsujimoto M, Monden M, and Matsuura N (2001) Expression of p57/Kip2 protein in hepatocellular carcinoma. Oncology (Basel) 61:221-225.
17. Ito Y, Takeda T, Sasaki Y, Sakon M, Yamada T, Ishiguro S, Imaoka S, Tsujimoto M, Monden M, and Matsuura N (2002) Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma. Liver 22:145-149.
18. Katiyar SK (2003) Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr Drug Targets Immune Endocr Metabol Disord 3:234-242.
19. Lee MH, Reynisdottir I, and Massague J (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649.
20. Lippens S, Kockx M, Knaapen M, Mortier L, Polakowska R, Verheyen A, Garmyn M, Zwijsen A, Formstecher P, Huylebroeck D, et al. (2000) Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Diff 7:1218-1224.
21. Lippens S, VandenBroecke C, Van Damme E, Tschachler E, Vandenabeele P, and Declercq W (2003) Caspase 14 is expressed in the epidermis, the choroid plexus, the retinal pigment epithelium and thymic Hassall's bodies. Cell Death Diff 10:257-259.
22. Madison KC (2003) Barrier function of the skin: "la raison d'etre" of the epidermis. J Investig Dermatol 121:231-241.
23. Martinez LA, Chen Y, Fischer SM, and Conti CJ (1999) Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation. Oncogene 18:397-406.
24. Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, and Salvesen GS (2004) Activation and substrate specificity of caspase-14. Biochemistry 43:10560-10569.
25. Miyazawa T (2000) Absorption, metabolism and antioxidative effects of tea catechin in humans. Biofactors 13:55-59.
26. Mukhtar H and Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71:1698S-1702S.
27. Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K, Watanabe S, and Kuriyama S (2002) Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. Int J Oncol 20:769-775.
28. Nickoloff BJ, Qin JZ, Chaturvedi V, Bacon P, Panella J, and Denning MF (2002) Life and death signaling pathways contributing to skin cancer. J Investig Dermatol Symp Proc 7:27-35.
29. Nishimori S, Tanaka Y, Chiba T, Fujii M, Imamura T, Miyazono K, Ogasawara T, Kawaguchi H, Igarashi T, Fujita T, et al. (2001) Smad-mediated transcription is required for transforming growth factor-beta 1-induced p57(Kip2) proteolysis in osteoblastic cells. J Biol Chem 276:10700-10705.
30. Opalka B, Dickopp A, and Kirch HC (2002) Apoptotic genes in cancer therapy. Cells Tissues Organs 172:126-132.
31. Oya M and Schulz WA (2000) Decreased expression of p57(KIP2) mRNA in human bladder cancer. Br J Cancer 83:626-631.
32. Rendl M, Ban J, Mrass P, Mayer C, Lengauer B, Eckhart L, Declerq W, and Tschachler E (2002) Caspase-14 expression by epidermal keratinocytes is regulated by retinoids in a differentiation-associated manner. J Investig Dermatol 119:1150-1155.
33. Takahashi K, Nakayama K, and Nakayama K (2000) Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. J Biochem (Tokyo) 127:73-83.
34. Urano T, Yashiroda H, Muraoka M, Tanaka K, Hosoi T, Inoue S, Ouchi Y, and Toyoshima H (1999) p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. J Biol Chem 274:12197-12200.
35. Vattemi G, Tonin P, Filosto M, Spagnolo M, Rizzuto N, and Tomelleri G (2000) T-cell anti-apoptotic mechanisms in inflammatory myopathies. J Neuroimmunol 111:146-151.
36. Watanabe H, Pan ZQ, Schreiber-Agus N, DePinho RA, Hurwitz J, and Xiong Y (1998) Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 95:1392-1397.
37. Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H, Sone H, Shimano H, Gotoda T, Nishimori S, et al. (2003) p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 278:52919-52923.
38. Yoneda K, Yokoyama T, Yamamoto T, Hatabe T, and Osaki T (1999) p53 gene mutations and p21 protein expression induced independently of p53, by TGF-beta and gamma-rays in squamous cell carcinoma cells. Eur J Cancer 35:278-283.